Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report

Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.

Similar Articles


Most Popular


You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign